Herpes simplex virus 1 (HSV-1) is a pathogen which primarily infects the oral mucosa. Glycoprotein B (gB) plays an essential role in HSV infection and is highly conserved among different herpesviruses. It is component of the virion envelope, elicits high titers of neutralizing antibody, functions in penetration of virions into host cells (ts mutation), and evidence suggests that gB forms complexes with submembrane proteins (syn mutation). Analyses of the nucleotide sequence and hydropathicity of gB predict that it contains an extracellular hydrophilic domain, a hydrophobic transmembrane region, and a charged carboxyl terminus projecting into the cytoplasm. Studies are designed to elucidate the requirements for the various functions of gB and to verify aspects of the structure of the molecule focusing on the extracellular region and the carboxyl terminus. 1) We are continuing to map antigenic and functional domains on the hydrophilic region of gB by marker rescue of mutants resistant to potent neutralizing monoclonal antibodies. Cognitive sites of antibodies will be mapped by reconstructing the gB with small, in-frame deletions using a panel of DNaseI deletions clones. 2) We will map the boundies of the domain of the syn locus at the charged carboxyl terminus of mutants in gB. By inducing compensatory mutations across the genome, genes encoding proteins which form complexes with gB will be identified by marker rescue with wild type DNA fragments. 3) Contributions of specific N- linked glycosylation sites to the structure, function, and transport of gB will be studied using site-directed mutagenesis to alter the consenus sequence for carbohydrate addition. gB constructs will be expressed in cells containing a resident HSV-1 alpha 4 gene by transfecting with DNA of plasmids carrying the gB gene linked to the dihydrofolate reductase gene resistant to methotrexate. Analysis of gB functions in virions will be carried out by superinfecting cells producing gB constitutively with conditional lethal mutants in gB or by recombining gB constructs into the viral genome. Ultimately, these data will contribute to our understanding of the functional topology of the gB molecule.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Research Project (R01)
Project #
5R01DE008275-03
Application #
3222075
Study Section
Experimental Virology Study Section (EVR)
Project Start
1987-05-01
Project End
1990-08-31
Budget Start
1989-05-01
Budget End
1990-08-31
Support Year
3
Fiscal Year
1989
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
Schools of Dentistry/Oral Hygn
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Navarro, D; Qadri, I; Pereira, L (1993) Transport and secretion of truncated derivatives of herpes simplex virus 1 glycoprotein B. Virology 192:234-45
Navarro, D; Paz, P; Pereira, L (1992) Domains of herpes simplex virus I glycoprotein B that function in virus penetration, cell-to-cell spread, and cell fusion. Virology 186:99-112
Wooden, S K; Li, L J; Navarro, D et al. (1991) Transactivation of the grp78 promoter by malfolded proteins, glycosylation block, and calcium ionophore is mediated through a proximal region containing a CCAAT motif which interacts with CTF/NF-I. Mol Cell Biol 11:5612-23
Navarro, D; Qadri, I; Pereira, L (1991) A mutation in the ectodomain of herpes simplex virus 1 glycoprotein B causes defective processing and retention in the endoplasmic reticulum. Virology 184:253-64
Qadri, I; Gimeno, C; Navarro, D et al. (1991) Mutations in conformation-dependent domains of herpes simplex virus 1 glycoprotein B affect the antigenic properties, dimerization, and transport of the molecule. Virology 180:135-52
Pereira, L; Qadri, I; Navarro, D et al. (1990) Antigenic and structural properties of mutants in herpes simplex virus 1 glycoprotein B. Adv Exp Med Biol 278:165-82
Kohl, S; Strynadka, N C; Hodges, R S et al. (1990) Analysis of the role of antibody-dependent cellular cytotoxic antibody activity in murine neonatal herpes simplex virus infection with antibodies to synthetic peptides of glycoprotein D and monoclonal antibodies to glycoprotein B. J Clin Invest 86:273-8
Pereira, L; Ali, M; Kousoulas, K et al. (1989) Domain structure of herpes simplex virus 1 glycoprotein B: neutralizing epitopes map in regions of continuous and discontinuous residues. Virology 172:11-24
Banks, T; Huo, B; Kousoulas, K et al. (1989) A major neutralizing domain maps within the carboxyl-terminal half of the cleaved cytomegalovirus B glycoprotein. J Gen Virol 70 ( Pt 4):979-85
Kousoulas, K; Arsenakis, M; Pereira, L (1989) A subset of type-specific epitopes map in the amino terminus of herpes simplex virus type 1 glycoprotein B. J Gen Virol 70 ( Pt 3):735-41

Showing the most recent 10 out of 13 publications